Whole Food Plant-Based Diet Explored to Improve Prostate Cancer Outcomes, Reduce Risk Factors
Background
Prostate cancer progression and mortality are significantly linked to obesity, a major public health concern. For men with prostate cancer experiencing rising prostate-specific antigen (PSA) levels, current management often involves monitoring or more aggressive treatments with side effects. Prior research suggests that dietary interventions, such as low-fat diets and exercise, can positively influence prostate cancer models and obese men. This study addresses the gap in understanding how a whole food plant-based diet specifically impacts PSA and other metabolic risk factors associated with treatment.
Study Design
This six-month study enrolls men with prostate cancer and rising PSA levels. Participants attend twelve two-hour plant-based cooking and nutrition classes and adopt a mostly whole food plant-based diet. Primary endpoint is change in PSA levels. Secondary endpoints include LDL cholesterol, hemoglobin A1C, and C-reactive protein, measured via blood samples. Three-day food journals assess nutrient intake.
Why It Matters
If successful, this research could establish a whole food plant-based diet as a significant non-pharmacological intervention for men with prostate cancer experiencing rising PSA. This could offer a complementary or alternative strategy to manage disease progression and mitigate metabolic risk factors often exacerbated by conventional treatments. Integrating dietary changes into standard care could empower patients, potentially improving quality of life and reducing reliance on more invasive therapies. The study's focus on practical cooking classes suggests a scalable model for patient education, moving closer to a usable protocol for dietary management in oncology.
prostate-cancer
plant-based-diet
psa
diet
nutrition
clinical-trial